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        Study Design.     Cross-sectional study. 
      Objective.     To examine the sensitivity of 2 single-item questions 
compared with 2 longer questionnaires for screening depression 
and anxiety among patients with chronic low back pain (CLBP). 
      Summary of Background Data.     Psychosocial factors are 
frequently identiﬁ   ed as risk factors for developing CLBP and as 
predictors for treatment, and questionnaires are often used to screen 
for this. Shorter instruments may be easier to use in clinical practice 
settings. 
      Methods.     A total of 564 patients with 2 to 10 months of at least 50% 
sickness absence due to nonspeciﬁ  c low back pain were assessed for 
depression and anxiety with the Mini-International Neuropsychiatric 
Interview (MINI). Single-item questions for depression and anxiety 
from the Subjective Health Complaint Inventory and 2 longer 
questionnaires, the Hospital Anxiety and Depression Scale and 
Hopkins Symptom Checklist–25, were compared with MINI 
results, considered the “gold standard” in this study. Sensitivity and 
speciﬁ   city of single-item and longer questionnaires and receiver 
operating characteristic curves were compared. 
      Results.     According to MINI, the prevalence of anxiety disorders 
was 12% whereas that of depressive disorders was 4%. The screening 
questions showed 95% sensitivity and 56% speciﬁ  city for depressive 
disorders and 68% sensitivity and 85% speciﬁ   city for anxiety 
disorders. The longer questionnaire, Hospital Anxiety and Depression 
Scale, showed 91% sensitivity and 85% speciﬁ  city for depressive 
disorders and 58% sensitivity and 83% speciﬁ   city for anxiety 
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          C
omorbid psychiatric symptoms are frequently reported 
in patients with chronic low back pain (CLBP).  1   Con-
current psychiatric symptoms in CLBP imply poor 
prognosis,  2   poor outcome,  3   and high health care utilization.  4   
Previous research with a focus on comorbidity has primarily 
been on depression,  5   but recent ﬁ  ndings also emphasize the 
importance of anxiety in this patient group.  6–8   
  Physicians are not always successful in identifying and 
recognizing psychiatric symptoms. Between 30% and 50% 
of patients with depression fail to be recognized by their 
primary care physicians.  9   Unrecognized psychiatric symp-
toms bear consequences on an individual level as well as at 
the societal level. Undertreatment of psychological disorders 
and increased disability costs are 2 such examples.  10    ,    11   Clini-
cal guidelines emphasize the importance of screening for psy-
chiatric symptoms in patients with CLBP,  12   and systematic 
reviews from primary care further indicate that screening for 
depression can improve outcomes by reducing the risk of per-
sistent depression.  13–15   
  Several short and accurate instruments for detecting depres-
sion are available,  16–19   and systematic reviews have found 
short instruments to be as good as longer questionnaires in 
detecting depression and, possibly, anxiety.  13    ,    18   In a study of 
patients with low back pain (LBP), a 2-item screening test was 
even more accurate in screening for depressive symptoms than 
physical therapists’ ratings were.  19   Previous research related 
to screening of depression has primarily been conducted 
disorders. Hopkins Symptom Checklist–25 showed 86% sensitivity 
and 74% speciﬁ  city for depressive disorders and 67% sensitivity and 
87% speciﬁ  city for anxiety disorders. For 3 of the anxiety disorders 
and 2 of the depressive disorders, a perfect sensitivity was found 
between the screening questions and MINI. 
      Conclusions.     A single-item screening question was sensitive for 
depression but less sensitive for anxiety. The screening questions 
further performed equal to 2 widely used questionnaires. Validation 
of these results in other populations and compared with other short-
item screeners is needed. 
        Key words:      chronic low back pain    ,     screening    ,     depression    ,     anxiety    , 
    comorbidity sick leave   ,    single-item screening   ,    psychiatric symptoms   , 
    diagnostic tool    ,     risk screening    . 
    Level of Evidence:   3 
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in primary care settings,  20   with little focus on screening for 
psychiatric symptoms in secondary care. Yet, patients with 
CLBP are frequently seen in secondary care settings where 
psychiatric symptoms are either not acknowledged or the 
patients are subjected to a range of different questionnaires 
as part of the standard medical procedures. Recent ﬁ  ndings 
have indicated that one simple question might be enough 
to screen for depression in different chronic pain popula-
tions when a validated questionnaire was used as the “gold 
standard.”  21   However, these results need to be tested with a 
diagnostic interview as the “gold standard” comparator. In 
the current study, the Mini-International Neuropsychiatric 
Interview (MINI) was used as the “gold standard.” MINI is 
a short-structured interview with high reliability and validity 
for assessing psychiatric disorders.  22   Furthermore, few studies 
have focused on anxiety as well as depression screening in 
patients with CLBP despite the fact that anxiety and pain-
related fear may be more strongly correlated with LBP dis-
ability than with depression,  8   and more disabling than the 
pain itself.  23   
  The aim of this study was to compare the sensitivity of 
2 single-item screening questions for depression and anxi-
ety, with 2 longer, widely used, and validated questionnaires, 
against a diagnostic interview to determine whether the sin-
gle-item screening questions could be enough to screen for 
depression and anxiety in patients with CLBP.     
  MATERIALS AND METHODS   
  Sample and Procedure 
  A total of 564 patients sick-listed 2 to 10 months for nonspe-
ciﬁ  c LBP were included in the study. They were all consecutive 
participants in an ongoing clinical trial (the CINS trial) for 
LBP, recruited through written invitation from the National 
Insurance Administration.  24   The inclusion criteria of the trial 
were age 20 to 60 years, sick-listed at least 50% for 2 to 10 
months due to nonspeciﬁ  c LBP, and at least 50% employed. 
Exclusion criteria were pregnancy, osteoporosis (known 
osteoporotic fracture), hemophilia, cancer, recent back 
trauma, serious psychiatric disorder (mainly due to ongoing 
psychosis, high suicide risk, and/or serious depression), car-
diovascular disease, ongoing insurance trial (workers’ com-
pensation claim), and not ﬂ  uent in the Norwegian language. 
Sixty-three participants were excluded because of 1 or more 
of these criteria. At baseline, all patients completed validated 
questionnaires, had a clinical examination by a medical doc-
tor, and were screened for psychiatric diagnoses.     
  Psychiatric Interview 
  MINI, which is a structured diagnostic interview  22   for 
  Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition   (  DSM-IV  ),  25   and   International Classiﬁ  cation 
of Diseases, Tenth Revision   (  ICD-10  ),  26   assessing psychiat-
ric disorders, was used as the “gold standard” comparator 
in the current study. It is based on “yes” and “no” answers 
and covers 23 axis 1 disorders. In the multiaxial system of 
  DSM-IV  , axis I disorders include all major mental disorders. 
The interview usually takes 15 to 20 minutes and has high 
reliability and validity.  22   We used the Norwegian version of 
MINI plus.  27   The MINI plus is a version of MINI that is 
particularly designed for research. Various time frames are 
used for the different disorders: current, past, or lifetime. 
“Current” refers to past 2 weeks (major depression), past 
month (panic disorder, social phobia, obsessive-compulsive 
disorder, post-traumatic stress disorder [PTSD]), or ongoing 
at the time of the interview with no further time reference 
(agoraphobia, generalized anxiety disorder). In this study, 
we analyzed only current depressive disorders (consisting 
of 3 diagnoses: major depressive episode, major depres-
sive episode with melancholia, and dysthymia) and current 
anxiety disorders (consisting of 6 diagnoses: generalized 
anxiety disorder, agoraphobia, panic disorder, social phobia, 
obsessive compulsive disorder, and PTSD). The interviews 
were conducted by 8 medical doctors specialized in physi-
cal medicine and rehabilitation who had been trained in the 
administration of MINI. All interviews were audio taped, 
and 90 audiotapes were randomly selected for evaluation. 
The evaluations showed satisfactory quality of the majority 
of interviews. For interviewers with lower quality ratings, 
immediate feedback and supervision were provided. The 
interviewers administering MINI were blinded (masked) for 
the results of the 2 longer questionnaires and the single-item 
questions.     
  Screening Questionnaires 
  All patients ﬁ  lled out 2 longer, validated screening question-
naires assessing psychiatric symptoms. The sensitivity of these 
questionnaires was further compared with the single-item 
questions against the psychiatric interview. The following 2 
questionnaires were used:   
  Hospital Anxiety and Depression Scale 
  The Hospital Anxiety and Depression Scale (HADS) is a 
measure of anxiety and depression  28   where participants are 
asked to answer the questions on the basis of how they have 
been feeling over the past week. It has been found to be a 
reliable instrument for detecting states of depression and 
anxiety and is also a valid measure of severity of the emo-
tional disorders.  29   No somatic items or items concerning sleep 
problems are included, and the scale thus avoids overlap with 
somatic symptoms of physical illness. It consists of 7 items for 
depression and 7 items for anxiety. Scores for each item range 
from 0 to 3, and the higher the score, the more severe the 
disorder. Cronbach   α   coefﬁ  cients of internal consistency have 
been documented across several studies, with a mean of 0.83 
for anxiety and 0.82 for depression.  29   A cutoff score of 8 or 
more on both subscales was used because this has been found 
to give an optimal balance between sensitivity and speciﬁ  city 
(  ∼  0.80 for both subscales) according to   DSM-III  ,   DSM-IV  , 
  ICD-8  , and   ICD-9  .  29       
  Hopkins Symptom Checklist–25 
  Hopkins Symptom Checklist–25 (HSCL) measures anxiety 
and depressive symptoms  30   and has particularly been found to 
Copyright © 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
SPINE130044_LR   E456 SPINE130044_LR   E456 11/03/14   6:57 PM 11/03/14   6:57 PMEPIDEMIOLOGY  Screening in CLBP • Reme et al
Spine  www.spinejournal.com E457
be a reliable and valid questionnaire in identifying depressive 
symptoms.  31   The scale consists of 25 questions about the pres-
ence and intensity of the most common psychiatric symptoms 
of anxiety and depression, with response alternatives ranging 
from 1 (not bothered) to 4 (extremely bothered). The patients 
received the following instructions: “To what extent have 
you been bothered by the following symptoms in the last 14 
days including today?” Internal consistency has been found 
to be high, with Cronbach   α   coefﬁ  cients ranging from 0.84 
to 0.87.  30   We used the widely used cutoff of 1.75 to deﬁ  ne 
depression and anxiety on the respective subscales, which has 
been found to give an optimal balance between sensitivity and 
speciﬁ  city, particularly for females (0.82).  32    ,    33         
  Screening Questions 
  The screening questions were taken from the Subjective 
Health Complaints (SHC) inventory. The SHC inventory 
records complaints, without asking for attributions or medi-
cal diagnosis.  34   The selection of questions is not based on any 
speciﬁ  c theory but covers, instead, frequent health complaints 
and reasons for encounter with a general practitioner.  35   The 
SHC inventory consists of 29 questions concerning severity 
and duration of common health complaints. The participants 
received the following instructions: “On the following page 
you ﬁ  nd some common health problems and complaints. We 
want you to look at each and every one of them and report   to 
what extent you have been affected   during the last month.” 
The respondents report whether, and to what extent, they 
have been affected in the last 30 days, ranging from 0 to 3 
(0   =   not at all; 1   =   a little; 2   =   some; 3   =   serious). In the 
current study, we used only 2 questions concerning anxiety/
nervousness and depression/low mood. The exact wording of 
the anxiety and depression items on the SHC was “anxiety” 
for the anxiety item and “sad, depressed” for the depression 
item. They are further referred to as the screening questions.     
  Statistical Analysis 
  The primary outcome of the study was the reporting of sen-
sitivity and speciﬁ  city compared with the “gold standard.” 
Receiver operating characteristic (ROC) curves were used to 
examine the discriminating ability of the single-item screening 
questions compared with the “gold standard” (MINI). The 
area under the ROC curve (AUC) was calculated as a mea-
sure of the ability of the 2 single-item screening questions to 
discriminate between patients with and without a diagnosis 
of depression or anxiety. According to a rough guide,  36   an 
AUC between 0.70 and 0.80 represents a fair test, between 
0.80 and 0.90 represents a good test, and between 0.90 and 
1 represents an excellent test. Sensitivity and speciﬁ  city and 
positive and negative predictive values were calculated. To 
study whether HADS and HSCL had additional information 
compared with the screening questions, we made ROC curves 
based on predicted probabilities from logistic regression mod-
els (generalized linear models), including the screening ques-
tions as continuous variables and then entering HADS and 
HSCL subsequently, ﬁ  rst, as categorical variables and, second, 
as continuous variables. Testing of additional statistical signif-
icant contribution to the AUC was based on likelihood ratio 
test from the generalized linear models. The statistical analy-
ses were performed in SPSS (version 18) and the statistical 
program “R” (version 2.13;   http://www.r-project.org  ) using 
the libraries veriﬁ  cation and gam.     
  Ethical Considerations 
  The Regional Ethical Committee and the Norwegian Social 
Science Data Services approved the study. All principles of 
the Helsinki declaration were followed. Informed consent 
was signed by each participant, with emphasis on the right 
to withdraw from the study at any time without any expla-
nation. The trial is registered at   http://www.clinicaltrials.gov  , 
with registration number NCT00463970.       
  RESULTS 
  The study population comprised 50.5% females. Mean age of 
the population was 45 years, and the participants reported an 
average of 11 years’ duration of their back pain (  Table 1  ). The 
prevalence of current depressive disorders was 4% (n   =   21) 
and the prevalence of current anxiety disorders was 12% 
(n   =   69), as assessed by the “gold standard” (MINI). Missing 
data were largest on the single anxiety question (6.2%; 
n   =   35) and depression question (5.9%; n   =   33), with some-
what less on HSCL (3.0%; n   =   17), HADS (2.2%; n   =   12), 
and MINI (1.8%; n   =   10).     
  Prevalence of Psychiatric Symptoms 
  According to HADS, 18% of the patients (n   =   100) scored 
above the cutoff for depression and 23% (n   =   125) scored 
above the cutoff for anxiety. According to HSCL, 29% 
(n   =   156) scored above the cutoff for depression and 20% 
(n   =   111) scored above the cutoff for anxiety. On the basis 
of the 2 single-item screening questions, 46% (n   =   243) 
reported to have been bothered by depression whereas 22% 
(n   =   115) reported to have been bothered by anxiety during 
the last month.     
  Discriminating Abilities of the Screening Questions to 
Identify Depression and Anxiety   
  Depression 
  The screening question for depression showed good discrimi-
nating abilities in identifying depressive disorders as assessed 
by MINI. The single-item screening question showed 95% 
sensitivity in detecting current depressive disorders but some-
what low speciﬁ  city (56%) (  Table 2  ). For 2 of the 3 depres-
sive diagnoses, major depressive episode (100%; 95% conﬁ  -
dence interval [CI]   =   0.77–1.0) and dysthymia (100%; 95% 
CI   =   0.31–1.0), a perfect sensitivity was observed, meaning 
that the screening question could identify every patient with 
an ongoing depressive episode or dysthymia. The AUC when 
the screening question was included as a continuous vari-
able (0, 1, 2, 3) was 0.90 (95% CI   =   0.82–0.97), whereas 
AUC values for the different response alternatives were some-
what lower (  Table 2  ), implying that the single-item screen-
ing question is an excellent screening item to identify patients 
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with depressive symptoms that may or may not represent a 
depressive disorder.   
  One of the longer questionnaires (HADS) showed similar 
discriminating abilities as the single-item screening question, 
with 91% sensitivity and 85% speciﬁ  city (  Table 2  ). The AUC 
was 0.88 (95% CI   =   0.80–0.95). The other longer ques-
tionnaire (HSCL) showed similar but poorer discriminating 
abilities, with 86% sensitivity and 74% speciﬁ  city (  Table 2  ). 
The AUC was 0.80 (95% CI   =   0.71–0.89). We found no 
statistical signiﬁ  cant gain from including information from 
HSCL when it was added to the screening question in the 
logistic regression model, neither as a categorical variable nor 
as a continuous variable. HADS had a statistically signiﬁ  cant 
impact on the relation to MINI, but the change in the AUC 
was low and may not have practical or clinical consequences. 
The discriminating abilities of HADS, HSCL, and the screen-
ing question were further visualized in   Figure 1  .       
  Anxiety 
  The screening question for anxiety did not show as good 
discriminating abilities in identifying anxiety disorders deter-
mined by MINI (  Table 3  ). The screening question showed a 
somewhat low sensitivity (68%) but a high speciﬁ  city (85%). 
However, for 3 of the anxiety diagnoses, a perfect sensitiv-
ity was found: panic disorder (100%; 95% CI   =   0.56–1.0), 
obsessive-compulsive disorder (100%; 95% CI   =   0.52–1.0), 
and PTSD (100%; 95% CI   =   0.31–1.0). The AUC when 
included as a continuous variable (0, 1, 2, 3) was 0.79 (95% CI 
  =   0.72–0.86), whereas AUC values for the different response 
alternatives were somewhat lower (  Table 3  ), implying that the 
screening question is a fair/good screening question to identify 
patients with anxiety disorders.   
  One of the longer questionnaires (HADS) showed poorer 
discriminating abilities than the single-item screening ques-
tion, with only 58% sensitivity and 83% speciﬁ  city, which 
gives an AUC of 0.70 (95% CI   =   0.63–0.78). The other 
longer questionnaire (HSCL) showed similar discriminating 
abilities as the screening question, with 67% sensitivity and 
87% speciﬁ  city. The AUC indicated that it is a fair test in 
Copyright © 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
  TABLE 1.       Baseline and Clinical Characteristics 
(N   =   564)   
Continuous Variables Mean SD Median
Age, yr 45 9.8 45
Duration of back pain, yr 11 10.5 7.5
Back pain intensity (0–10) 6.5 1.9 7
Pain during activity (0–10) 5.9 2.1 6
Pain while resting (0–10) 4.0 2.3 4
Subjective Health Complaints, 
 no.  complaints 10 4.9 10
  Categorical Variables   n   % 
Sex
 Male 273 49.5
 Female 278 50.5
Civil status
 Married/cohabitant 396 71.9
 Single/widow/divorced 155 28.1
Education
  Primary school 1–12 yr 385 70.1
 University/college 164 29.9
  TABLE 2.       Discriminating Abilities of the Single-Item Depression Question, HADS, and HSCL When 
Compared With MINI (N   =   525)   
Depression Screening
Sensitivity 
(95% CI)
Speciﬁ  city 
(95% CI)
Overall 
Accuracy
PPV 
(95% CI) NPV (95% CI) AUC 95% CI
Screening question*: 0   vs  . 1 and 2 and 3 95% 
(77.3–99.2)
56% 
(52.0–60.6) 58% 8% 
(5.5–12.5)
100% 
(98.0–99.9)
0.76 
(0.68–0.83)
Screening question  †  : 0 and 1   vs  . 2 and 3 81% 
(60.0–92.3)
89% 
(85.9–91.3) 89% 23% 
(15.1–34.2)
99% 
(97.8–99.7)
0.85 
(0.75–0.95)
Screening question  ‡  : 0 and 1 and 2   vs  . 3 33% 
(17.2–54.6)
99% 
(97.7–99.6) 96% 58% 
(32.0–80.7)
97% 
(95.5–98.4)
0.66 
(0.52–0.81)
HADS-Depression  (score   ≥  8) 91% 
(71.1–97.4)
84% 
(81.2–87.4) 85% 19% 
(12.5–27.8)
100% 
(98.4–99.9)
0.88 
(0.80–0.95)
HSCL-Depression  (score   ≥  1.75) 86% 
(65.4–95.0)
74% 
(69.9–77.4) 74% 12% 
(7.5–17.7)
99% 
(98.4–99.9)
0.80 
(0.71–0.89)
  *Not affected by depression at all   versus   a little, some, seriously affected. 
    †  Not or a little affected by depression   versus   some or seriously affected. 
    ‡  Not, a little or some affected   versus   seriously affected. 
  HADS indicates Hospital Anxiety and Depression Scale; HSCL, Hopkins Symptom Checklist; MINI, Mini-International Neuropsychiatric Interview; CI, conﬁ  dence 
interval; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the receiver operating characteristic curve. 
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identifying anxiety disorders (0.77; 95% CI   =   0.70–0.84). 
There was a statistically signiﬁ  cant increase in the AUC for 
HADS and for HSCL when they were added to the screening 
question in the logistic regression model, but the changes in 
AUC were relatively small (  Table 4  ). The discriminating abili-
ties of HADS, HSCL, and the screening question are further 
visualized in   Figure 2  .             
  DISCUSSION 
  The aim of this study was to determine whether 2 single-item 
screening questions would be enough to screen for depression 
and anxiety in patients with CLBP. The results showed that 
the single-item screening questions were sensitive for depres-
sion but less sensitive for anxiety. Compared with 2 widely 
used and validated questionnaires, the 2 screening questions 
performed similar in identifying patients with depression 
and anxiety. The AUC values indicated that the screening 
questions are good/excellent in detecting depression and fair/
good in detecting anxiety disorders in this group of patients. 
  In seeking to identify patients with certain diagnoses in 
routine clinical practice, a 2-step process is often undertaken 
where a short screening test with high sensitivity is used to 
identify potential individuals with the condition. For those 
who screen positive, a second, often more detailed test with 
greater speciﬁ  city is used to conﬁ  rm. It should, however, be 
noted that setting the threshold of a test at high sensitivity 
leads to a large number of false-positive tests, which can be 
burdensome in clinical practice.  16   For that reason, we exam-
ined different cutoff points of the various response alterna-
tives of the screening questions and found the ﬁ  rst option 
listed in   Tables 2 and 3   (not affected by depression at all   vs  . 
a little, some, seriously affected) to be the preferred cutoff. 
However, the optimal accuracy (maximizing the combination 
of sensitivity and speciﬁ  city) for the depression question was 
the second option (not or a little affected by depression   vs  . 
some or seriously affected). 
  When each diagnosis of either depression or anxiety was 
analyzed separately, the results revealed that the screening 
questions had a perfect sensitivity for 3 anxiety disorders 
(panic disorder, obsessive-compulsive disorder, and PTSD) 
and 2 depressive disorders (major depressive episode and 
dysthymia). 
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  Figure 1.       Receiver operating characteristic curves for HADS, HSCL, 
and the single-item screening question for depression. HADS indicates 
Hospital Anxiety and Depression Scale; HSCL, Hopkins Symptom 
Checklist; D, depression.   
  TABLE 3.       Discriminating Abilities of the Single-Item Anxiety Question, HADS, and HSCL When 
Compared With MINI (N   =   545)   
Anxiety Screening
Sensitivity 
(95% CI)
Speciﬁ  city 
(95% CI)
Overall 
Accuracy
PPV 
(95% CI)
NPV 
(95% CI)
AUC 
(95% CI)
Screening question*: 0   vs  . 1 and 2 and 3 68% 
(55.6–77.8)
85% 
(81.4–87.9) 83% 39% 
(30.5–48.2)
95% 
(92.3–96.6)
0.76 
(0.69–0.83)
Screening question  †  : 0 and 1   vs  . 2 and 3 46% 
(34.6–58.1)
96% 
(94.1–97.7) 90% 64% 
(49.5–76.0)
93% 
(90.0–94.7)
0.71 
(0.63–0.79)
Screening question  ‡  : 0 and 1 and 2   vs  . 3 11% 
(5.3–20.6)
100% 
(99.2–100) 89% 100% 
(64.6–100)
89% 
(85.7–91.2)
0.55 
(0.47–0.63)
HADS-Anxiety (score   ≥  8) 58% 
(46.2–68.9)
83% 
(79.1–85.9) 80% 33% 
(25.1–41.5)
93% 
(90.3–95.2)
0.70 
(0.63–0.78)
HSCL-Anxiety (score   ≥  1.75) 67% 
(54.9–76.7)
87% 
(83.3–89.4) 84% 42% 
(33.4–51.6)
95% 
(92.1–96.4)
0.77 
(0.70–0.84)
  *Not affected by anxiety at all   versus   a little, some, seriously affected. 
    †  Not or a little affected by anxiety   versus   some or seriously affected. 
    ‡  Not, a little or some affected   versus   seriously affected. 
  HADS indicates Hospital Anxiety and Depression Scale; HSCL, Hopkins Symptom Checklist; MINI, Mini-International Neuropsychiatric Interview; CI, conﬁ  -
dence interval; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the receiver operating characteristic curve. 
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  Depression is known to be a common comorbid disorder 
in patients with CLBP,  5   and the need to screen for depres-
sion has previously been highlighted in clinical guidelines.  12   
Anxiety, however, has received far less attention as a comorbid 
condition in patients with CLBP. Yet, in the current study, anx-
iety disorders were more prevalent than depressive disorders. 
In a recent study looking at a range of different factors associ-
ated with disability due to CLBP, anxiety showed the strongest 
association with disability.  8   Furthermore, pain-related fear has 
been found to be more disabling than the pain itself in chronic 
back pain,  23   and the disabling consequences of anxiety are as 
severe as depression when combined with chronic musculo-
skeletal pain.  37   This suggests that screening for anxiety disor-
ders may be as important as for depression in patients with 
CLBP. Given our results, additional work is needed to identify 
more sensitive instruments to screen for anxiety. 
  In research, the depression screening question could replace 
longer screening instruments to identify potentially depressed 
patients, particularly in cases where length is a concern. 
Although the single anxiety question was less sensitive than 
the depression question, and therefore may be insufﬁ  cient 
as a screening tool in clinical practice, it still showed similar 
or better discriminating abilities than the 2 longer question-
naires. We thus suggest that the anxiety question could be 
suitable for epidemiological studies, to replace longer ques-
tionnaires, whereas the depression question could be suit-
able as a screening tool in clinical practice to identify patients 
with a possible depressive disorder. Clinical interviews take 
both time and resources to conduct, so a single-item screen-
ing question that could identify those in need of such clini-
cal assessments would be highly beneﬁ  cial and cost-effective. 
The screening question is further simple and easy to admin-
ister and therefore has good prospects for implementation 
in clinical practice. Previous studies from primary care have 
concluded that 1-question tests are unacceptable as screening 
tools for depression.  15   Other short screening tools, such as the 
Patient Health Questionnaire–2, have shown good promise 
in identifying depressive  17   and anxiety disorders  18   in various 
medical populations. An avenue for future research could 
thus be to compare the single-item screening questions with 
the Patient Health Questionnaire–2 to determine which may 
be most appropriate for specialists who care for patients with 
LBP conditions. 
  A possible limitation of the study is the surprisingly low 
prevalence of psychiatric symptoms in this group of patients 
with CLBP on sick leave. This is particularly so for depression 
Copyright © 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
  TABLE 4.       AUC for the Single-Item Screening Questions   Versus   MINI, and Additional Contributions 
From HADS and HSCL   
Anxiety Depression
AUC (95% CI)   P  * AUC (95% CI)   P  *
Screening question 0.79 (0.72–0.86) Ref 0.90 (0.82–0.97) Ref
Screening question   +   HADS  †  0.81 (0.75–0.88) 0.031 0.92 (0.85–0.99)   <  0.001
Screening question   +   HSCL  †  0.83 (0.77–0.90) 0.013 0.91 (0.85–0.97) 0.79
Screening question   +   HADS  ‡  0.85 (0.79–0.90)   <  0.001 0.94 (0.91–0.98)   <  0.001
Screening question   +   HSCL  ‡  0.86 (0.81–0.91) 0.010 0.92 (0.87–0.98) 0.093
  For depression, there were 519 observations (21 cases), and for anxiety, there were 517 observations (65 cases). 
  *  P   values are based on likelihood ratio tests from logistic regression analyses (generalized linear model). 
    †  HADS and HSCL entered as categorical variables. 
    ‡  HADS and HSCL entered as continuous variables. 
  AUC indicates area under the receiver operating characteristic curve; MINI, Mini-International Neuropsychiatric Interview; CI, conﬁ  dence interval; HADS, 
Hospital Anxiety and Depression Scale; HSCL, Hopkins Symptom Checklist. 
   
  Figure 2.       Receiver operating characteristic curves for HADS, HSCL, 
and the single-item screening question for anxiety. HADS indicates 
Hospital Anxiety and Depression Scale; HSCL, Hopkins Symptom 
Checklist; A, anxiety.   
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  ➢  Key  Points   
              Simple screening tools to identify patients with 
CLBP and psychiatric diagnoses are needed.   
              Two single-item screening questions are able to 
identify most patients with CLBP with depression 
and some with anxiety.   
              The screening questions performed equal to or 
better than 2 longer screening questionnaires.           
when compared with previous literature.  38   It raises ques-
tions whether those who administered MINI were unduly 
conservative in interpreting responses, which could affect the 
generalizability of the ﬁ  ndings to some degree. However, in 
the study, thorough procedures were undertaken to ensure the 
quality and reliability of the interviews. This involved training 
and supervision of interviewers, audio taping of interviews, 
and evaluation of a random selection of interviews to assess 
adherence and quality of administration. No major protocol 
deviations or poor quality results were revealed in the evalu-
ations. Possible explanations for the somewhat lower preva-
lence of psychiatric symptoms compared with ﬁ  ndings from 
other studies are discussed elsewhere  6   but could be related to 
different population and settings of the various studies. This 
could be an avenue for future studies to pursue. Another 
potential limitation is the different time frames of the various 
screening instruments, which could inﬂ   uence their screen-
ing sensitivity: the single-item screening questions measured 
symptoms of the past 30 days, HSCL in the past 14 days, and 
HADS during the past week, whereas MINI examined cur-
rent symptoms with various criteria for time frames depend-
ing on the diagnosis (14 d for current depression, 30 d for 
anxiety disorders). In diagnostic screening tests, we want to 
be as inclusive as possible to ensure a high sensitivity, as pre-
viously mentioned. A wider time frame, such as the 30-day 
frame applied in the single-item screening questions, might 
thus be preferred. Furthermore, this could possibly be part 
of the explanation for the high sensitivity we found for at 
least one of the screening questions compared with the longer 
questionnaires with shorter time frames.     
  CONCLUSION 
  The results showed that the single-item screening questions 
were sensitive for depression but less sensitive for anxiety. 
They both performed similar to 2 widely used and validated 
questionnaires; the depression question had very high sensi-
tivity but less speciﬁ  city, whereas the anxiety question had 
similar or better sensitivity and speciﬁ  city than the 2 longer 
questionnaires. In both cases, however, follow-up assessments 
would be needed to conﬁ  rm a diagnosis of either depression 
or anxiety. Furthermore, the results need to be validated in 
other populations before any widespread use in clinical and 
epidemiological settings can be recommended.        
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